Cancer News: Brain
Chemotherapy and radiation after surgery improves survival in adult patients with medulloblastoma.
Stereotactic radiosurgery has shown better results in survival, less cognitive decline and better quality of life compared to whole brain radiotherapy.
Metastatic brain cancer patients treated with stereotactic radiosurgery had less cognitive deterioration three months after treatment, a study finds.
Elderly glioblastoma patients lived longer after being treated with chemoradiation using temozolomide, new research reveals.
Adding a second autologous stem-cell transplant to treatment improved outcomes for children with high-risk neuroblastoma, a new research shows.
Treating younger adults with low-grade glioma with chemo-radiation rather than radiotherapy alone improved overall survival, a new study reveals.
A new promising method may be able to identify brain cancer patients who will benefit from immunotherapy, UCLA researchers report.
Treatment with proton radiotherapy in childhood brain cancer resulted in fewer side effects and similar survival rates as conventional radiotherapy.
Brain cancer patients survived longer when treated with Optune in combination with Avastin, a new late-stage study reveals.
A patient with a BRAF-mutant brain tumor benefited from the melanoma treatment, dabrafenib, revealing the potential of the drug against this type of brain tumor.
Advaxis’ experimental cancer vaccine improved survival rates in patients of cervical cancer compared with standard therapy, the company announced.
A new study reveals the specific structural and continuous brain changes resulting from standard radiation and chemotherapy in patients with glioblastoma.
Patients with low-grade brain tumors live longer now than in the past due to more effective chemotherapies, a new study shows.
Patients with low-grade glioma, a type of brain cancer, benefited from combining chemotherapy with radiation therapy, new clinical findings suggest.
Long term use of hormonal contraceptives has been associated with a possible increase in a young woman's risk of developing glioma, a rare brain tumor.
Results from a recent preclinical study have shown that a new drug combination therapy being developed effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors (glioblastoma multiforme) survived longer than five years after diagnosis, according to Cedars-Sinai researchers.
A research team has now achieved success with a novel form of treatment that involves encouraging the body's own immune system to recognize and eliminate cancer cells in the brain.
Brain cancer is one of the most common causes of cancer death. Current methods can diagnose the cancer within 2 to 3 days, but researchers say they have created a new technique in which the disease could be diagnosed in just half an hour.
Advanced imaging techniques can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Imaging results could also be used to predict progression-free survival.
Brain cancer immune cells function may be compromised due to the disease. Researchers identified a drug that may re-activate them, and could lead to potential treatment.
Glioblastoma (GBM) tumor cells can evade targeted therapies, as shown recently, by essentially hiding the signaling molecule targeted by such therapies. This may affect new treatment strategies.
An experimental vaccine could improve the survival of patients with a lethal brain tumor called glioblastoma multiforme, compared with standard care alone. This research was published in the journal Neuro-Oncology.
New targets for glioblastoma, which are believed to drive the grow and recurrence of this brain tumor, have been identified.
Research on brain cancer stem cells has identified immune system targets, and even an experimental vaccine.
Cancer metastasis from the breast to the brain may be due to a protein, according to new research.
Glioblastoma multiforme is the most common and most aggressive form of brain cancer. Scientists identified a new gene behind this tumor, which may be a target for new treatments.
A mutated gene in rare brain tumors (craniopharyngiomas) has been identified, possibly leading to better treatment. The cancer is currently treated with surgeries & radiation.
Advanced surgery techniques for identifying cancerous brain cells may improve outcomes for glioblastoma multiforme patients, a tumor with usually poor prognosis.
A study of 621 adults showed that adding bevacizumab to the standard of care for glioblastoma (GBM) did not improve overall survival.